Methylenetetrahydrofolate reductase gene and coronary artery disease

Circulation

Volumn 95, Issue 1, 1997, Pages 21-23

  Van Bockxmeer, Frank M ^a   Mamotte, Cyril D S ^a   Vasikaran, Samuel D ^a   Taylor, Roger R ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

cardiovascular diseases; genes; homocysteine; restenosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY RISK; GENE MUTATION; HEART INFARCTION; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; RISK ASSESSMENT;

EID: 0031025577     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.1.21     Document Type: Article

References (10)

1. McCully KS. Vascular pathology of homocysteinemia. Am J Pathol. 1969;56:111-128.
2. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest. 1976;57:1079-1082.
3. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 1995;274:1049-1057.
4. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
5. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
6. Risk Factor Prevalence Study Management Committee. Risk Factor Prevalence Study Survey No 3, 1989. Canberra, Australia: National Heart Foundation of Australia and Australian Institute of Health; 1990.
7. van Bockxmeer FM, Mamotte CDS, Gibbons FA, Burke V, Taylor RR. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation. 1995;92:2066-2071.
8. Kang SS, Passen EL, Ruggie N, Wong PWK, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1993;88:1463-1469.
9. Wu LL, Wu J, Hunt SC, James BC, Vincent GM, Williams RR, Hopkins PN. Plasma homocysteine as a risk factor for early familial coronary artery disease. Clin Chem. 1994;40:522-561.
10. Tsai JC, Perrella MA, Yoshizumi M, Hseh CM, Haber E, Schlegel R, Lee ME. Promotion of vascular smooth muscle cell growth by homocysteine: link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91:6369-6373.